Coordinated Response to Imported Vaccine-Derived Poliovirus Infection, Barcelona, Spain, 2019-2020.
Barcelona
Spain
adverse effects
complications
disease eradication
immunologic deficiency syndromes
oral
poliovirus vaccine
surveillance
vaccine-preventable diseases
vaccines
viruses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
entrez:
26
4
2021
pubmed:
27
4
2021
medline:
6
7
2021
Statut:
ppublish
Résumé
In 2019, the Public Health Agency of Barcelona, Spain, was notified of a vaccine-derived poliovirus infection. The patient had an underlying common variable immunodeficiency and no signs of acute flaccid paralysis. We describe the ongoing coordinated response to contain the infection, which included compassionate-use treatment with pocapavir.
Identifiants
pubmed: 33900188
doi: 10.3201/eid2705.204675
pmc: PMC8084499
doi:
Substances chimiques
Poliovirus Vaccine, Oral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1513-1516Références
BMC Infect Dis. 2016 May 26;16:231
pubmed: 27230071
Front Immunol. 2017 Jun 13;8:685
pubmed: 28952612
Emerg Infect Dis. 2016 Oct;22(10):1712-9
pubmed: 27648512
J Clin Immunol. 2015 Nov;35(8):696-726
pubmed: 26482257
PLoS Pathog. 2015 Aug 27;11(8):e1005114
pubmed: 26313548
Lancet Microbe. 2020 Oct;1(6):e243
pubmed: 33047110
Front Immunol. 2017 Sep 25;8:1103
pubmed: 28993765
J Infect Dis. 2014 Nov 1;210 Suppl 1:S368-72
pubmed: 25316857
BMC Infect Dis. 2015 Sep 17;15:379
pubmed: 26382043
Immunotherapy. 2015;7(12):1273-92
pubmed: 26289364